# Zhejiang Huahai Pharmaceutical

> Zhejiang Huahai Pharmaceutical is a VC fund in Linhai backing Biotechnology and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Linhai, China
- Total investments: 2
- Last investment: Jul 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/浙江华海药业股份有限公司
- Website: http://en.huahaipharm.com/

Zhejiang Huahai Pharmaceutical is a VC fund in Linhai focused on Biotechnology and Pharmaceutical. Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Therapeutics | 1 | 50% |
| Medical Device | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 50% |
| Finland | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Yannuo Pharmaceutical | Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas. |  | Series A | Jul 07, 2023 |  |
| Aurealis Therapeutics | They exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with their four-in-one biologic drug, AUP-16. Their goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by endof 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients. | $10M | Series A | Mar 30, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Lynx Capital](https://shizune.co/investors/profile/lynx-capital-3971) — VC Fund, 1 deal together
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund, 1 deal together
- [Zhejiang Starry Pharmaceutical](https://shizune.co/investors/profile/zhejiang-starry-pharmaceutical) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Finland](https://shizune.co/investors/biotechnology-investors-finland)
- [Biotechnology VC Funds in Finland](https://shizune.co/investors/biotechnology-vc-funds-finland)
- [Health Care VC Funds in Finland](https://shizune.co/investors/health-care-vc-funds-finland)
- [Biotech VC Funds in Finland](https://shizune.co/investors/biotech-vc-funds-finland)
- [Health Care Investors in Finland](https://shizune.co/investors/health-care-investors-finland)

## FAQ

### What does Zhejiang Huahai Pharmaceutical invest in?

Zhejiang Huahai Pharmaceutical invests primarily in Biotechnology, Pharmaceutical and Therapeutics startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhejiang Huahai Pharmaceutical last invest?

The most recent investment recorded for Zhejiang Huahai Pharmaceutical closed in Jul 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co